The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.
The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.
The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.
The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.
The goal of this activity is to improve participants’ competence in implementing the most recent guideline changes and clinical advances in the management of patients with indolent non-Hodgkin’s lymphomas.
Lung cancer is the leading cause of cancer death in the United States. Oncologists need to be aware of new treatment options and recommendations so they can implement the best treatment plans and thus improve outcomes for their patients with lung cancer.
Facebook
Twitter
LinkedIn
Forward